MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
62 hedge funds and large institutions have $98.5M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.
Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
18
Reduced
10
Closed
6
Calls
$2.38M
Puts
$407K
Net Calls
+$1.98M
Net Calls Change
-$860K
Top Buyers
1 |
1
BlackRock
New York
|
$8.32M |
2 |
2
State Street
Boston,
Massachusetts
|
$2.14M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$3M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$6.85M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$1.43M |